NCT07031167 · NOT YET RECRUITING

The COMFORTage Project at Ace Alzheimer Center Barcelona

This trial is testing whether a personalized digital training program combining cognitive and physical exercises can help slow memory and thinking decline in people with mild cognitive impairment or early Alzheimer's. Participants do weekly in-person sessions for one year using tablet and computer-based tools, then are followed for a second year. It is a Phase NA randomized trial — comparing the program against no intervention to see if it makes a measurable difference.

You may qualify if

  • Age between 60 and 85 years.
  • Diagnosis of MCI based on Petersen criteria with a CDR score of 0.5.
  • Diagnosis of mild AD dementia according to National Institute on Aging-Alzheimer's Association (NIA-AA) criteria with a CDR score of 1.
  • Proficiency in using digital tools such as mobile apps, tablets, or computers.
  • Ability and willingness to attend regular in-person sessions at Ace Alzheimer Center Barcelona.
  • Provided written informed consent after receiving a full explanation of the study.

You're excluded if

  • History of traumatic brain injury.
  • Diagnosis of severe depression.
  • History of stroke or brain tumors.
  • Presence of significant uncorrected visual or auditory impairments.
  • Lack of access to a digital device or internet connection.
  • Inability to participate in regular in-person sessions at the study site.
  • Any medical condition that may confound cognitive assessment or limit participation.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-06-22

View full record on ClinicalTrials.gov

All APOE4 clinical trials